Inotiv Inc. (NOTV) Event Nov. 29, 2022, 01:14 UTC 119 0 comments Inotiv - Q4 FY 2022 Financial Results Conference Comment Full text
Pfizer Inc (PFE) Event Nov. 28, 2022, 18:01 UTC 112 0 comments Pfizer Inc. - 5th Annual Evercore ISI HealthCONx Conference Comment Full text
Mirati Therapeutics Inc (MRTX) Event Nov. 28, 2022, 16:03 UTC 109 0 comments Mirati Therapeutics Inc. - Mirati Therapeutics ESMO IO 2022 Virtual Investor Event Comment Full text
Ionis Pharmaceuticals Inc (IONS) Event Nov. 28, 2022, 15:00 UTC 105 0 comments Ionis Pharmaceuticals Inc - Evercore ISI 5th Annual HealthCONx Comment Full text
Ionis Pharmaceuticals Inc (IONS) Event Nov. 28, 2022, 15:00 UTC 110 0 comments Ionis Pharmaceuticals Inc - Piper Sandler 34th Annual Healthcare Conference Comment Full text
Atara Biotherapeutics Inc (ATRA) Event Nov. 23, 2022, 16:06 UTC 106 0 comments Atara Biotherapeutics to present at Evercore ISI 5th Annual HealthCONx Conference Comment Full text
Rain Therapeutics Inc (RAIN) Event Nov. 23, 2022, 16:00 UTC 116 0 comments Rain Therapeutics Announces a Poster Presentation at the 2022 San Antonio Breast Cancer Symposium Comment Full text
Sage Therapeutics Inc (SAGE) Event Nov. 23, 2022, 14:33 UTC 105 0 comments Sage Therapeutics Inc - Piper Sandler Healthcare Conference Comment Full text
Agilent Technologies Inc. (A) Event Nov. 22, 2022, 00:07 UTC 104 0 comments Agilent Technologies, Inc. - Q422 Results Presentation Comment Full text
Genmab (GMAB) Event Nov. 21, 2022, 16:01 UTC 108 0 comments Genmab Announces U.S. Food and Drug Administration Accepts for Priority Review Biologics License Application (BLA) for Epcoritamab(DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) Comment Full text